loading
Telomir Pharmaceuticals Inc stock is traded at $2.0689, with a volume of 323.22K. It is up +0.49% in the last 24 hours and up +64.80% over the past month. Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.
See More
Previous Close:
$2.05
Open:
$2.02
24h Volume:
323.22K
Relative Volume:
0.12
Market Cap:
$61.51M
Revenue:
-
Net Income/Loss:
$-13.08M
P/E Ratio:
-4.685
EPS:
-0.4416
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+64.80%
6M Performance:
-54.42%
1Y Performance:
-45.93%
1-Day Range:
Value
$2.00
$2.15
1-Week Range:
Value
$2.00
$2.44
52-Week Range:
Value
$1.12
$8.40

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name
Name
Telomir Pharmaceuticals Inc
Name
Phone
786-396-6723
Name
Address
100 SE 2ND ST, MIAMI
Name
Employee
5
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
TELO's Discussions on Twitter

Compare TELO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TELO
Telomir Pharmaceuticals Inc
2.0667 64.81M 0 -13.08M 0 -0.4416
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
471.17 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.51 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
344.20 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
605.20 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
302.15 31.87B 3.81B -644.79M -669.77M -6.24

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-21-25 Initiated Rodman & Renshaw Buy

Telomir Pharmaceuticals Inc Stock (TELO) Latest News

pulisher
05:52 AM

Real time social sentiment graph for Telomir Pharmaceuticals Inc.Free Entry Plan for Oversold Reversal Stocks - Newser

05:52 AM
pulisher
04:52 AM

Technical analysis overview for Telomir Pharmaceuticals Inc. stockFree Weekly Top Gainers Forecast Watchlist - Newser

04:52 AM
pulisher
Jul 29, 2025

Chart Analysts Warn of Resistance Near Telomir Pharmaceuticals Inc. PriceHigh Yield Stock Screening Results Explained - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Top Risks to Consider Before Buying Telomir Pharmaceuticals Inc. StockFree Pattern Breakout Entry Stock Forecast - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Will Telomir Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsFree Intraday Trend Analysis for Fast Gains - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

What makes Telomir Pharmaceuticals Inc. stock price move sharplyAI Trading Forecast Based on Big Data - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Visual trend scoring systems applied to Telomir Pharmaceuticals Inc.Free Oversold Bounce Stock Play Ideas - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Can volume confirm reversal in Telomir Pharmaceuticals Inc.Profitable Trading Blueprint with Entry Zones - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Why is Telomir Pharmaceuticals Inc. stock attracting strong analyst attentionFree Stock Outlook That Work - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Telomir Pharmaceuticals Inc. stock in 2025High-velocity gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Telomir Pharmaceuticals Inc. meeting your algorithmic filter criteriaSwing Reversal Forecast Based on Patterns - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Telomir Pharmaceuticals Inc. company’s balance sheetFree Daily Trading Room Entry - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How volatile is Telomir Pharmaceuticals Inc. stock compared to the marketExplosive capital appreciation - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Telomir Pharmaceuticals Inc. stockInvest confidently with expert support - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 01:15:26 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Telomir Pharmaceuticals Inc. stock expected to show significant growthBuild a portfolio that outperforms the market - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 20:33:38 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Telomir Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveLow Risk ROI Maximization - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Competitive Positioning of Telomir Pharmaceuticals Inc.: Is It Leading or LaggingTop Performing Low Risk Stocks - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Telomir Pharmaceuticals Inc. stockFree Smart Trading Workshop - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathway - Lansing State Journal

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Telomir Pharmaceuticals Inc. stock priceUnstoppable profit momentum - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

When is the best time to buy Telomir Pharmaceuticals Inc. stockSuperior risk-adjusted returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Telomir Pharmaceuticals stock surges on promising Progeria treatment results - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Telomir Pharmaceuticals stock surges on promising Progeria treatment results By Investing.com - Investing.com India

Jul 24, 2025
pulisher
Jul 24, 2025

Telomir Pharmaceuticals announces new preclinical data on Telomir-1 - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Telomir-1 shows promise in restoring mitochondrial function By Investing.com - Investing.com India

Jul 24, 2025
pulisher
Jul 24, 2025

Telomir-1 shows promise in restoring mitochondrial function - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

Revolutionary Mitochondrial Drug Could Transform Treatment of Alzheimer's, Parkinson's, and ALS - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Telomir Pharmaceuticals Inc. Stock Analysis and ForecastExceptional trading results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Telomir Pharmaceuticals Inc (NASDAQ: TELO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

Jul 23, 2025
pulisher
Jul 23, 2025

Telomir Pharmaceuticals Inc (TELO) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Telomir Pharmaceuticals Inc. a good long term investmentExceptional trading results - jammulinksnews.com

Jul 22, 2025

Telomir Pharmaceuticals Inc Stock (TELO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$78.00
price up icon 0.76%
$37.35
price up icon 0.20%
$107.04
price up icon 1.94%
$27.15
price up icon 1.55%
$112.09
price up icon 0.55%
biotechnology ONC
$302.52
price down icon 1.16%
Cap:     |  Volume (24h):